Two people can have the same diagnosis and respond differently to the same treatment.
Precision medicine asks whether genomics, health records, lifestyle and other data can help explain those differences and improve decisions.
Did you know that Singapore has already completed whole-genome sequencing for more than 100,000 residents and is now moving into a much larger Phase III precision-medicine programme?
This article targets precision medicine Singapore, genomics Singapore, bioinformatics Singapore, genetic testing Singapore and National Precision Medicine Singapore.
Official information was checked on 4 October 2026. This is a research and economic explainer, not medical advice.
Did You Know? Singapore Has Sequenced More Than 100,000 Residents
Singapore’s National Precision Medicine Programme completed whole-genome sequencing for more than 100,000 Singapore residents under Phase II.
PRECISE says this created one of the world’s largest multi-ethnic Asian genomic datasets.
Official reference: PRECISE — Singapore’s National Precision Medicine Programme.
Phase III Is Much Larger
In October 2026, MOH said Singapore aims to recruit a further 450,000 participants over the coming years under Phase III.
Earlier 2026 MOH material described a target range of roughly 400,000 to 450,000 participants.
Official reference: MOH — Precision Health Partnerships in Singapore.
The programme is moving from dataset creation toward real clinical implementation.
What Is a Genome?
A genome is the complete set of genetic material in an organism.
Human genomes contain billions of DNA letters.
Most are shared across people.
The differences can influence traits, disease risk and response to some medicines.
Genomics studies these patterns at large scale.
Precision Medicine Is Broader Than Genetics
Genomic information is one input.
Clinical records, lifestyle, environment and family history also matter.
The aim is not to reduce a person to DNA.
It is to combine several layers of information to make better health decisions.
Worked Example: Risk Is Not Destiny
Imagine a fictional genetic variant doubles the risk of a disease from 1% to 2%.
That is a 100% relative increase and a 1 percentage-point absolute increase.
The person is still far more likely not to develop the disease.
Genetic risk needs careful communication because relative and absolute risk can sound very different.
Bioinformatics Turns DNA Into Usable Information
Sequencing machines produce enormous files containing raw DNA reads.
Bioinformatics software aligns those reads, identifies variants and compares them with reference data.
The computational pipeline turns biological material into interpretable information.
Genomics is therefore partly a data-centre and software industry.
Genomics Requires Large-Scale Compute
One whole genome can contain hundreds of gigabytes of raw data depending on sequencing method and depth.
Population-scale studies multiply that across tens or hundreds of thousands of people.
Storage, high-performance computing and cloud infrastructure become research tools.
See Making Singapore Rich | Cloud Software, SaaS and Enterprise Technology.
Singapore Is Building Secure Cloud-Native Genomic Infrastructure
In October 2026, MOH announced partnerships involving PRECISE, AWS and Temus to develop secure, scalable cloud-native genomic infrastructure and combine genomics with AI and engineering.
Official reference: MOH — Precision Health Partnerships.
The infrastructure is as important as the sequencing machines.
Why Asian Genomic Data Matters
Many global genomic datasets historically overrepresented populations of European ancestry.
That can reduce the accuracy of risk prediction and variant interpretation in other populations.
Singapore’s multi-ethnic Asian dataset helps fill that evidence gap.
The country’s diversity becomes a research asset.
Precision Medicine Is Moving Into Clinical Use
MOH has highlighted familial hypercholesterolaemia as one early use case where genetic testing is being used nationally to identify higher-risk individuals and relatives.
Official reference: MOH — Precision Health Partnerships.
The value of genomics is measured by useful decisions, not sequencing volume.
Pharmacogenomics Connects Genes to Medicines
Some genetic variants affect how the body metabolises medicines.
Pharmacogenomics studies whether genetic information can help select or dose certain treatments more effectively.
The field can reduce trial-and-error in suitable cases.
It does not mean every prescription needs a genetic test.
Worked Example: Preventing a Wrong Treatment Has Economic Value
Imagine a fictional test costs S$300 and prevents a S$5,000 hospitalisation in one out of twenty tested high-risk patients.
The expected avoided hospital cost is S$250 per test before considering treatment outcomes and other costs.
The test may or may not be economical depending on the full clinical evidence.
Health economics converts scientific benefit into resource decisions.
Clinical Interpretation Requires Experts
A DNA variant can be common, rare, harmful, harmless or uncertain.
Geneticists, genetic counsellors and clinicians interpret results in context.
A raw sequence is not a diagnosis.
The human expertise around the data remains essential.
Genetic Counselling Is an Information Service
Genetic information can affect family members as well as the individual tested.
Counsellors help people understand what a result means, what it does not mean and what decisions are available.
The value is careful communication under uncertainty.
Precision Medicine Connects to Clinical Trials
Genomic biomarkers can help identify patients more likely to respond to specific therapies.
Trials can use molecular information to define subgroups.
See Making Singapore Rich | Clinical Trials, Contract Research and Biomedical Translation.
Research becomes more targeted when disease biology is better understood.
Precision Medicine Connects to Diagnostics
Genetic tests are a type of diagnostic technology.
They require laboratories, sequencing platforms, bioinformatics pipelines and clinical interpretation.
See Making Singapore Rich | Medical Device Manufacturing, Diagnostics and Regulatory Engineering.
AI Can Find Patterns Humans Cannot See Easily
Machine learning can analyse genomic variants alongside medical records and imaging.
The challenge is validation, bias and explainability.
A model trained on one population may not transfer perfectly to another.
Local data helps build locally relevant AI.
The Risk: Genetic Information Is Sensitive
A genome cannot be changed like a password.
It can also reveal information about biological relatives.
Data protection, access control and governance are therefore unusually important.
See Making Singapore Rich | Data Privacy, PDPA and Privacy Engineering.
Singapore Is Developing Additional Genetic-Information Safeguards
MOH said in October 2026 that Singapore had consulted on proposed legislation governing use of genetic information in non-clinical settings, starting with insurance and employment.
The policy goal is to allow people to benefit from genomic medicine without fearing unfair disadvantage from genetic predispositions.
Official reference: MOH — Genetic Information Safeguards.
The Risk: Genetic Determinism
Genes influence risk.
They do not explain every outcome.
Lifestyle, environment, age and random biological variation also matter.
Precision medicine should improve probabilistic decisions, not create false certainty.
The Risk: More Data Can Create More Incidental Findings
Sequencing can reveal information unrelated to the original reason for testing.
Health systems need policies about which findings should be returned, under what conditions and with what counselling.
More information is not automatically more useful information.
The Risk: Genomic Medicine Can Widen Inequality
Advanced testing and targeted therapies can be expensive.
If benefits are available only to wealthy patients, the technology can widen health disparities.
Singapore’s national approach matters because scale and public-health integration can reduce that risk.
Genomics Creates an Industry Around Data and Diagnostics
Sequencing companies, laboratories, software firms, pharmaceutical companies and digital-health providers can all build products around genomic capability.
Singapore’s programme creates a local evidence base and technical workforce that can support those industries.
The dataset itself is not the product.
The economic value comes from useful applications built responsibly around it.
Education Builds Genomic Literacy
Students need biology to understand DNA, statistics to understand risk and computing to understand bioinformatics.
They also need ethics and communication skills because genetic information affects real people and families.
See Making Singapore Rich | Education, Skills and Human Capital.
A Guided Classroom Investigation
Give students a fictional disease with a 1% baseline risk.
A genetic marker doubles that risk.
Ask students to calculate absolute and relative risk changes.
Then ask why the result should not be described as “you will get the disease”.
The exercise teaches probability and responsible communication.
Independent Practice: Sequence Everyone?
A fictional health system can spend S$100 million on sequencing or on another prevention programme.
Which creates more health benefit?
Students should ask about disease prevalence, actionable findings, treatment availability and cost effectiveness.
The learning goal is evidence-based resource allocation.
What Progress Should Look Like
A stronger precision-medicine economy should produce better Asian genomic evidence, secure bioinformatics infrastructure, clinically useful testing, responsible safeguards and more diagnostics and therapeutics built on local data.
A stronger learner should distinguish genetic risk from destiny, raw sequence from diagnosis and data volume from health impact.
Frequently Asked Questions
How many Singapore genomes have been sequenced?
Phase II of the National Precision Medicine Programme completed whole-genome sequencing for more than 100,000 Singapore residents.
What is the Phase III target?
MOH said in October 2026 that Singapore aims to recruit a further 450,000 participants over the coming years.
What is bioinformatics?
Bioinformatics uses computing, statistics and biological knowledge to analyse genomic and other biological data.
Does a genetic risk mean someone will definitely get a disease?
No. Genetic information changes probabilities; most diseases also depend on other biological, environmental and lifestyle factors.
How does precision medicine make Singapore richer?
It creates high-value genomics, diagnostics, bioinformatics, AI and biomedical-research capabilities while improving the evidence base for healthcare innovation.
Helpful Reading and Singapore Graph Connections
- PRECISE — National Precision Medicine Programme
- MOH — Precision Health Partnerships in Singapore
- MOH — NMRC Research Symposium 2026
- Making Singapore Rich | Clinical Trials, Contract Research and Biomedical Translation
- Making Singapore Rich | Healthcare, MedTech and the Health Economy
Making Singapore Rich: Turn Genomic Data Into Responsible Decisions
Did you know that the value of sequencing 100,000 genomes is not the number 100,000?
The value appears when researchers find robust patterns, clinicians can act on them, patients understand the meaning and safeguards preserve trust.
Singapore becomes richer when genomics becomes a platform for diagnostics, bioinformatics, AI and evidence-based healthcare innovation.
The sequence creates the data.
Precision medicine turns the data into a better question about what to do next.